IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Eiger Biopharmaceuticals Inc (72C)

CUSIP: 28249U204 | GR | 24 institutional holders

Quarters

Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2025

Propel Bio Management, LLC146,381
0.5% of portfolio›$423.0K
StyleTurnoverLocationFiled
Propel Bio Management, LLC
146,381$423.0K0.5%ValueHighLos Angeles, CA2025-08-13